Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.40 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 0.38 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 0.38 |
| ▸ | TAS1R2 | Q8TE23 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20278740 | 0.84 | NPC1 (0.32) | TAS1R3TAS1R1LMNAALDH1A1POLB | |
| SCHEMBL17483151 | 0.84 | TRPV1 (0.47) | TRPV1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL19483601 | 0.84 | TRPV1 (0.42) | TRPV1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL19484147 | 0.84 | TRPV1 (0.51) | TRPV1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL19484138 | 0.84 | TRPV1 (0.38) | TRPV1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL19484137 | 0.83 | TRPV1 (0.45) | TRPV1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL19484151 | 0.83 | TRPV1 (0.40) | TRPV1TAS1R3TAS1R1TAS1R2LMNA | |
| SCHEMBL19484127 | 0.81 | KMT2A (0.48) | TAS1R3TAS1R1TAS1R2LMNAALDH1A1 | |
| SCHEMBL20278663 | 0.79 | MEN1 (0.36) | LMNAALDH1A1HPGDSMN1; SMN2HTT | |
| SCHEMBL19484133 | 0.78 | KMT2A (0.38) | TAS1R3TAS1R1TAS1R2LMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170295789-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2017-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170295789-A1 | AMIDE COMPOUND AND USE OF SAME FOR NOXIOUS ARTHROPOD CONTROL | OPRM1, TRPA1, L3MBTL3 | TRPV1 52/4885TAS1R3 1080/4885TAS1R1 1146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.